Different metastasis promotive potency of small G-proteins RalA and RalB in in vivo hamster tumor model

Cancer Cell International

Elena M Tchevkina¹  Lyubov S Trukhanova¹  Vasily N Aushev¹  Andrei V Komelkov¹  Anna V Knizhnik¹  Vera A Rybko¹ 

[1] Department of Oncogenes Regulation, Institute of Carcinogenesis, Russian N.N. Blokhin Cancer Research Center, Kashirskoye shosse 24, 115478, Moscow, Russia

关键词: tumor growth;    Ral effector mutants;    invasion;    Ral proteins;    metastasis;   

Others  :  795502
DOI  :  10.1186/1475-2867-11-22

 received in 2011-02-08, accepted in 2011-06-29,  发布年份 2011

【 摘 要 】

Background

Previously we have shown that oncogenic Ha-Ras stimulated in vivo metastasis through RalGEF-Ral signaling. RalA and RalB are highly homologous small G proteins belonging to Ras superfamily. They can be activated by Ras-RalGEF signaling pathway and influence cellular growth and survival, motility, vesicular transport and tumor progression in humans and in animal models. Here we first time compared the influence of RalA and RalB on tumorigenic, invasive and metastatic properties of RSV transformed hamster fibroblasts.

Methods

Retroviral vectors encoding activated forms or effector mutants of RalA or RalB proteins were introduced into the low metastatic HET-SR cell line. Tumor growth and spontaneous metastatic activity (SMA) were evaluated on immunocompetent hamsters after subcutaneous injection of cells. The biological properties of cells, including proliferation, clonogenicity, migration and invasion were determined using MTT, wound healing, colony formation and Boyden chamber assays respectively. Protein expression and phosphorylation was detected by Westen blot analysis. Extracellular proteinases activity was assessed by substrate-specific zymography.

Results

We have showed that although both Ral proteins stimulated SMA, RalB was more effective in metastasis stimulation in vivo as well as in potentiating of directed movement and invasion in vitro. Simultaneous expression of active RalA and RalB didn't give synergetic effect on metastasis formation. RalB activity decreased expression of Caveolin-1, while active RalA stimulated MMP-1 and uPA proteolytic activity, as well as CD24 expression. Both Ral proteins were capable of Cyclin D1 upregulation, JNK1 kinase activation, and stimulation of colony growth and motility. Among three main RalB effectors (RalBP1, exocyst complex and PLD1), PLD1 was essential for RalB-dependent metastasis stimulation.

Conclusions

Presented results are the first data on direct comparison of RalA and RalB impact as well as of RalA/RalB simultaneous expression influence on in vivo cell metastatic activity. We showed that RalB activation significantly more than RalA stimulates SMA. This property correlates with the ability of RalB to stimulate in vitro invasion and serum directed cell movement. We also found that RalB-PLD1 interaction is necessary for the acquisition of RalB-dependent high metastatic cell phenotype. These findings contribute to the identification of molecular mechanisms of metastasis and tumor progression.

【 授权许可】

   
2011 Rybko et al; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

Figure 5.

【 参考文献 】

• [1]Leber MF, Efferth T: Molecular principles of cancer invasion and metastasis (review). IntJOncol 2009, 34:881-895.
• [2]Chardin P, Tavitian A: The ral gene: a new ras related gene isolated by the use of a synthetic probe. EMBO J 1986, 5:2203-2208.
• [3]Gildea JJ, Harding MA, Seraj MJ, Gulding KM, Theodorescu D: The role of Ral A in epidermal growth factor receptor-regulated cell motility. Cancer Res 2002, 62:982-985.
• [4]Oxford G, Owens CR, Titus BJ, Foreman TL, Herlevsen MC, Smith SC, Theodorescu D: RalA and RalB: antagonistic relatives in cancer cell migration. Cancer Res 2005, 65:7111-7120.
• [5]Feig LA, Urano T, Cantor S: Evidence for a Ras/Ral signaling cascade. Trends BiochemSci 1996, 21:438-441.
• [6]Chien Y, White MA: RAL GTPases are linchpin modulators of human tumour-cell proliferation and survival. EMBO Rep 2003, 4:800-806.
• [7]Smith SC, Theodorescu D: The Ral GTPase pathway in metastatic bladder cancer: key mediator and therapeutic target. Urol Oncol 2009, 27:42-47.
• [8]Chardin P, Tavitian A: Coding sequences of human ralA and ralB cDNAs. Nucleic Acids Res 1989, 17:4380.
• [9]Bodemann BO, White MA: Ral GTPases and cancer: linchpin support of the tumorigenic platform. NatRevCancer 2008, 8:133-140.
• [10]Ikeda M, Ishida O, Hinoi T, Kishida S, Kikuchi A: Identification and characterization of a novel protein interacting with Ral-binding protein 1, a putative effector protein of Ral. JBiolChem 1998, 273:814-821.
• [11]Kim JH, Lee SD, Han JM, Lee TG, Kim Y, Park JB, Lambeth JD, Suh PG, Ryu SH: Activation of phospholipase D1 by direct interaction with ADP-ribosylation factor 1 and RalA. FEBS Lett 1998, 430:231-235.
• [12]Ohta Y, Suzuki N, Nakamura S, Hartwig JH, Stossel TP: The small GTPase RalA targets filamin to induce filopodia. Proc Natl Acad Sci USA 1999, 96:2122-2128.
• [13]Moskalenko S, Tong C, Rosse C, Mirey G, Formstecher E, Daviet L, Camonis J, White MA: Ral GTPases regulate exocyst assembly through dual subunit interactions. JBiolChem 2003, 278:51743-51748.
• [14]Cascone I, Selimoglu R, Ozdemir C, Del NE, Yeaman C, White M, Camonis J: Distinct roles of RalA and RalB in the progression of cytokinesis are supported by distinct RalGEFs. EMBO J 2008, 27:2375-2387.
• [15]Lim KH, O'Hayer K, Adam SJ, Kendall SD, Campbell PM, Der CJ, Counter CM: Divergent roles for RalA and RalB in malignant growth of human pancreatic carcinoma cells. CurrBiol 2006, 16:2385-2394.
• [16]Yin J, Pollock C, Tracy K, Chock M, Martin P, Oberst M, Kelly K: Activation of the RalGEF/Ral pathway promotes prostate cancer metastasis to bone. MolCell Biol 2007, 27:7538-7550.
• [17]Smith SC, Oxford G, Baras AS, Owens C, Havaleshko D, Brautigan DL, Safo MK, Theodorescu D: Expression of ral GTPases, their effectors, and activators in human bladder cancer. ClinCancer Res 2007, 13:3803-3813.
• [18]Tchevkina E, Agapova L, Dyakova N, Martinjuk A, Komelkov A, Tatosyan A: The small G-protein RalA stimulates metastasis of transformed cells. Oncogene 2005, 24:329-335.
• [19]Shipitsin M, Feig LA: RalA but not RalB enhances polarized delivery of membrane proteins to the basolateral surface of epithelial cells. MolCell Biol 2004, 24:5746-5756.
• [20]Camonis JH, White MA: Ral GTPases: corrupting the exocyst in cancer cells. Trends Cell Biol 2005, 15:327-332.
• [21]Li G, Han L, Chou TC, Fujita Y, Arunachalam L, Xu A, Wong A, Chiew SK, Wan Q, Wang L, Sugita S: RalA and RalB function as the critical GTP sensors for GTP-dependent exocytosis. JNeurosci 2007, 27:190-202.
• [22]Smith SC, Oxford G, Wu Z, Nitz MD, Conaway M, Frierson HF, Hampton G, Theodorescu D: The metastasis-associated gene CD24 is regulated by Ral GTPase and is a mediator of cell proliferation and survival in human cancer. Cancer Res 2006, 66:1917-1922.
• [23]Li C, Lee CJ, Simeone DM: Identification of human pancreatic cancer stem cells. Methods Mol Biol 2009, 568:161-173.
• [24]Henry DO, Moskalenko SA, Kaur KJ, Fu M, Pestell RG, Camonis JH, White MA: Ral GTPases contribute to regulation of cyclin D1 through activation of NF-kappaB. MolCell Biol 2000, 20:8084-8092.
• [25]Li Z, Wang C, Prendergast GC, Pestell RG: Cyclin D1 functions in cell migration. Cell Cycle 2006, 5:2440-2442.
• [26]Li Z, Wang C, Jiao X, Lu Y, Fu M, Quong AA, Dye C, Yang J, Dai M, Ju X, Zhang X, Li A, Burbelo P, Stanley ER, Pestell RG: Cyclin D1 regulates cellular migration through the inhibition of thrombospondin 1 and ROCK signaling. Mol Cell Biol 2006, 26:4240-4256.
• [27]Goetz JG, Lajoie P, Wiseman SM, Nabi IR: Caveolin-1 in tumor progression: the good, the bad and the ugly. Cancer Metastasis Rev 2008, 27:715-735.
• [28]Sunaga N, Miyajima K, Suzuki M, Sato M, White MA, Ramirez RD, Shay JW, Gazdar AF, Minna JD: Different roles for caveolin-1 in the development of non-small cell lung cancer versus small cell lung cancer. Cancer Res 2004, 64:4277-4285.
• [29]Bauer B, Mirey G, Vetter IR, Garcia-Ranea JA, Valencia A, Wittinghofer A, Camonis JH, Cool RH: Effector recognition by the small GTP-binding proteins Ras and Ral. JBiolChem 1999, 274:17763-17770.
• [30]Moskalenko S, Henry DO, Rosse C, Mirey G, Camonis JH, White MA: The exocyst is a Ral effector complex. NatCell Biol 2002, 4:66-72.
• [31]Jiang H, Luo JQ, Urano T, Frankel P, Lu Z, Foster DA, Feig LA: Involvement of Ral GTPase in v-Src-induced phospholipase D activation. Nature 1995, 378:409-412.
• [32]Deichman GI, Kashleva HA, Kluchareva TE, Matveeva VA: Clustering of discrete cell properties essential for tumorigenicity and metastasis. II. Studies of Syrian hamster embryo fibroblasts transformed by Rous sarcoma virus. Int J Cancer 1989, 44:908-910.
• [33]Isachenko N, Dyakova N, Aushev V, Chepurnych T, Gurova K, Tatosyan A: High expression of shMDG1 gene is associated with low metastatic potential of tumor cells. Oncogene 2006, 25:317-322.
• [34]Tatosyan A, Yatsula B, Shtutman M, Moinova E, Kaverina I, Musatkina E, Leskov K, Mizenina O, Zueva E, Calothy G, Dezelee P: Two novel variants of the v-src oncogene isolated from low and high metastatic RSV-transformed hamster cells. Virology 1996, 216:347-356.
• [35]Zueva E, Rubio LI, Duconge F, Tavitian B: Metastasis-focused cell-based SELEX generates aptamers inhibiting cell migration and invasion. Int J Cancer 2011, 128:797-804.
• [36]Hamad NM, Elconin JH, Karnoub AE, Bai W, Rich JN, Abraham RT, Der CJ, Counter CM: Distinct requirements for Ras oncogenesis in human versus mouse cells. Genes Dev 2002, 16:2045-2057.
• [37]Rangarajan A, Hong SJ, Gifford A, Weinberg RA: Species- and cell type-specific requirements for cellular transformation. Cancer Cell 2004, 6:171-183.
• [38]Chien Y, Kim S, Bumeister R, Loo YM, Kwon SW, Johnson CL, Balakireva MG, Romeo Y, Kopelovich L, Gale M Jr, Yeaman C, Camonis JH, Zhao Y, White MA: RalB GTPase-mediated activation of the IkappaB family kinase TBK1 couples innate immune signaling to tumor cell survival. Cell 2006, 127:157-170.
• [39]Barbie DA, Tamayo P, Boehm JS, Kim SY, Moody SE, Dunn IF, Schinzel AC, Sandy P, Meylan E, Scholl C, Yeaman C, Camonis JH, Zhao Y, White MA: Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1. Nature 2009, 462:108-112.
• [40]Oxford G, Theodorescu D: The role of Ras superfamily proteins in bladder cancer progression. JUrol 2003, 170:1987-1993.
• [41]Nakashima S, Morinaka K, Koyama S, Ikeda M, Kishida M, Okawa K, Iwamatsu A, Kishida S, Kikuchi A: Small G protein Ral and its downstream molecules regulate endocytosis of EGF and insulin receptors. EMBO J 1999, 18:3629-3642.
• [42]Giavazzi R, Foppolo M, Dossi R, Remuzzi A: Rolling and adhesion of human tumor cells on vascular endothelium under physiological flow conditions. JClinInvest 1993, 92:3038-3044.
• [43]Lafrenie RM, Buchanan MR, Orr FW: Adhesion molecules and their role in cancer metastasis. Cell Biophys 1993, 23:3-89.
• [44]Aigner S, Ramos CL, Hafezi-Moghadam A, Lawrence MB, Friederichs J, Altevogt P, Ley K: CD24 mediates rolling of breast carcinoma cells on P-selectin. FASEB J 1998, 12:1241-1251.
• [45]Balakireva M, Rosse C, Langevin J, Chien YC, Gho M, Gonzy-Treboul G, Voegeling-Lemaire S, Aresta S, Lepesant JA, Bellaiche Y, White M, Camonis J: The Ral/exocyst effector complex counters c-Jun N-terminal kinase-dependent apoptosis in Drosophila melanogaster. MolCell Biol 2006, 26:8953-8963.
• [46]de Ruiter ND, Wolthuis RM, van DH, Burgering BM, Bos JL: Ras-dependent regulation of c-Jun phosphorylation is mediated by the Ral guanine nucleotide exchange factor-Ral pathway. MolCell Biol 2000, 20:8480-8488.
• [47]Norman KL, Hirasawa K, Yang AD, Shields MA, Lee PW: Reovirus oncolysis: the Ras/RalGEF/p38 pathway dictates host cell permissiveness to reovirus infection. Proc Natl Acad Sci USA 2004, 101:11099-11104.
• [48]Foster DA, Xu L: Phospholipase D in cell proliferation and cancer. MolCancer Res 2003, 1:789-800.
• [49]Shi M, Zheng Y, Garcia A, Xu L, Foster DA: Phospholipase D provides a survival signal in human cancer cells with activated H-Ras or K-Ras. Cancer Lett 2007, 258:268-275.
• [50]Zheng Y, Rodrik V, Toschi A, Shi M, Hui L, Shen Y, Foster DA: Phospholipase D couples survival and migration signals in stress response of human cancer cells. JBiolChem 2006, 281:15862-15868.
• [51]Shen Y, Xu L, Foster DA: Role for phospholipase D in receptor-mediated endocytosis. MolCell Biol 2001, 21:595-602.